{"id":5929,"date":"2025-02-26T11:43:31","date_gmt":"2025-02-26T11:43:31","guid":{"rendered":"https:\/\/integratedcarejournal.com\/?p=5929"},"modified":"2025-02-26T11:43:31","modified_gmt":"2025-02-26T11:43:31","slug":"new-national-data-shows-improved-respiratory-outcomes-with-digital-therapeutics","status":"publish","type":"post","link":"https:\/\/integratedcarejournal.com\/new-national-data-shows-improved-respiratory-outcomes-with-digital-therapeutics\/","title":{"rendered":"New national data shows improved respiratory outcomes with digital therapeutics"},"content":{"rendered":"

A respiratory digital therapeutics toolkit is improving outcomes and reducing health inequalities for people with asthma and chronic obstructive pulmonary disease (COPD) in Wales.<\/p>\n

The toolkit, which has reached full adoption across 100 per cent of GP practices and hospitals in NHS Wales, is providing a personalised, digital care plan that empowers hundreds of thousands of people to take control of their condition and stay well in the community.<\/p>\n

Professor Simon Barry, National Respiratory Clinical Lead at NHS Wales<\/a> (2016-2024), explained the impact the toolkit is having at a national scale: \u201cOverall, we\u2019re seeing patients showing a significant improvement in wellness scores in as little as three months. The biggest improvement is among patients using the asthma app for four months or more who are seeing their wellness score increase by 41 per cent. Users in socioeconomically deprived areas, and young people are seeing the greatest improvements in their Royal College of Physicians (RCP) 3-questions score.\u201d<\/p>\n

In addition, the toolkit has driven significant reductions in the use of reliever inhalers, an important marker of disease control:<\/p>\n